Avascular Necrosis of the Femoral Head
0
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
BiocorpFrance - Issoire
1 programAutologous Adipose Tissue derived MSCs TransplantationN/A1 trial
Active Trials
Zimmer BiometFL - Jacksonville
1 programPerFuse Percutaneous Decompression SystemN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Zimmer BiometPerFuse Percutaneous Decompression System
BiocorpAutologous Adipose Tissue derived MSCs Transplantation
Clinical Trials (2)
Total enrollment: 115 patients across 2 trials
Biologically Assisted Core Decompression of the Femoral Head Using the PerFuse Instrument and BioCUE
Start: Mar 2016Est. completion: Dec 2021100 patients
N/AUnknown
Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Avascular Necrosis of the Femoral Head
Start: May 2012Est. completion: Mar 201515 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.